Kristin K Jhamb, MD - Medicare Internal Medicine in Topsham, ME

Kristin K Jhamb, MD is a medicare enrolled "Internal Medicine" physician in Topsham, Maine. Her current practice location is 1 Wellness Way, Suite A, Topsham, Maine. You can reach out to her office (for appointments etc.) via phone at (207) 406-7600.

Kristin K Jhamb is licensed to practice in Maine (license number 014728) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1598771297.

Contact Information

Kristin K Jhamb, MD
1 Wellness Way, Suite A,
Topsham, ME 04086-1768
(207) 406-7600
(207) 406-7601



Physician's Profile

Full NameKristin K Jhamb
GenderFemale
SpecialityInternal Medicine
Location1 Wellness Way, Topsham, Maine
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1598771297
  • Provider Enumeration Date: 08/01/2006
  • Last Update Date: 01/20/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 6305820143
  • Enrollment ID: I20040617000904

Medical Identifiers

Medical identifiers for Kristin K Jhamb such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1598771297NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine 014728 (Maine)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Kristin K Jhamb allows following entities to bill medicare on her behalf.
Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467477349
PECOS PAC ID: 9335043967
Enrollment ID: O20031125000026

News Archive

People with SIRT1 genetic variation more likely to develop vibration-induced white finger disease

Vibration-induced white finger disease (VWF) is caused by continued use of vibrating hand held machinery (high frequency vibration >50 Hz), and affects tens of thousands of people. New research published in BioMed Central's open access journal Clinical Epigenetics finds that people with a genetic polymorphism (A2191G) in sirtuin1 (SIRT1), a protein involved in the regulation of endothelial NOS (eNOS), are more likely to suffer from vibration-induced white finger disease.

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

Cholesterol levels both high and low linked to premature births

A new study suggests that not only is a very low level of cholesterol a danger to pregnant women, but high cholesterol too increases the risk of premature birth.

Study shows that de novo mutations can be detected in human in vitro fertilized embryos using PGD

Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro fertilization (IVF).

New discovery opens new therapeutic opportunities for treatment of cancer and tissue fibrosis

Researchers from the Turku Centre for Biotechnology (BTK) in Finland have discovered that a cellular fuel sensor, known to control energy processes in the cells, is involved in the regulation of the contact of cells with their surrounding environment.

Read more Medical News

› Verified 9 days ago

Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598780447
PECOS PAC ID: 9335043967
Enrollment ID: O20040220000847

News Archive

People with SIRT1 genetic variation more likely to develop vibration-induced white finger disease

Vibration-induced white finger disease (VWF) is caused by continued use of vibrating hand held machinery (high frequency vibration >50 Hz), and affects tens of thousands of people. New research published in BioMed Central's open access journal Clinical Epigenetics finds that people with a genetic polymorphism (A2191G) in sirtuin1 (SIRT1), a protein involved in the regulation of endothelial NOS (eNOS), are more likely to suffer from vibration-induced white finger disease.

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

Cholesterol levels both high and low linked to premature births

A new study suggests that not only is a very low level of cholesterol a danger to pregnant women, but high cholesterol too increases the risk of premature birth.

Study shows that de novo mutations can be detected in human in vitro fertilized embryos using PGD

Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro fertilization (IVF).

New discovery opens new therapeutic opportunities for treatment of cancer and tissue fibrosis

Researchers from the Turku Centre for Biotechnology (BTK) in Finland have discovered that a cellular fuel sensor, known to control energy processes in the cells, is involved in the regulation of the contact of cells with their surrounding environment.

Read more Medical News

› Verified 9 days ago

Entity NameMaine Medical Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144245028
PECOS PAC ID: 9335043967
Enrollment ID: O20040331000321

News Archive

People with SIRT1 genetic variation more likely to develop vibration-induced white finger disease

Vibration-induced white finger disease (VWF) is caused by continued use of vibrating hand held machinery (high frequency vibration >50 Hz), and affects tens of thousands of people. New research published in BioMed Central's open access journal Clinical Epigenetics finds that people with a genetic polymorphism (A2191G) in sirtuin1 (SIRT1), a protein involved in the regulation of endothelial NOS (eNOS), are more likely to suffer from vibration-induced white finger disease.

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

Cholesterol levels both high and low linked to premature births

A new study suggests that not only is a very low level of cholesterol a danger to pregnant women, but high cholesterol too increases the risk of premature birth.

Study shows that de novo mutations can be detected in human in vitro fertilized embryos using PGD

Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro fertilization (IVF).

New discovery opens new therapeutic opportunities for treatment of cancer and tissue fibrosis

Researchers from the Turku Centre for Biotechnology (BTK) in Finland have discovered that a cellular fuel sensor, known to control energy processes in the cells, is involved in the regulation of the contact of cells with their surrounding environment.

Read more Medical News

› Verified 9 days ago

Entity NameRumford Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205991122
PECOS PAC ID: 3870583511
Enrollment ID: O20040514000890

News Archive

People with SIRT1 genetic variation more likely to develop vibration-induced white finger disease

Vibration-induced white finger disease (VWF) is caused by continued use of vibrating hand held machinery (high frequency vibration >50 Hz), and affects tens of thousands of people. New research published in BioMed Central's open access journal Clinical Epigenetics finds that people with a genetic polymorphism (A2191G) in sirtuin1 (SIRT1), a protein involved in the regulation of endothelial NOS (eNOS), are more likely to suffer from vibration-induced white finger disease.

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

Cholesterol levels both high and low linked to premature births

A new study suggests that not only is a very low level of cholesterol a danger to pregnant women, but high cholesterol too increases the risk of premature birth.

Study shows that de novo mutations can be detected in human in vitro fertilized embryos using PGD

Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro fertilization (IVF).

New discovery opens new therapeutic opportunities for treatment of cancer and tissue fibrosis

Researchers from the Turku Centre for Biotechnology (BTK) in Finland have discovered that a cellular fuel sensor, known to control energy processes in the cells, is involved in the regulation of the contact of cells with their surrounding environment.

Read more Medical News

› Verified 9 days ago

Entity NameMid Coast Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1932164795
PECOS PAC ID: 5496739468
Enrollment ID: O20040623001212

News Archive

People with SIRT1 genetic variation more likely to develop vibration-induced white finger disease

Vibration-induced white finger disease (VWF) is caused by continued use of vibrating hand held machinery (high frequency vibration >50 Hz), and affects tens of thousands of people. New research published in BioMed Central's open access journal Clinical Epigenetics finds that people with a genetic polymorphism (A2191G) in sirtuin1 (SIRT1), a protein involved in the regulation of endothelial NOS (eNOS), are more likely to suffer from vibration-induced white finger disease.

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

Cholesterol levels both high and low linked to premature births

A new study suggests that not only is a very low level of cholesterol a danger to pregnant women, but high cholesterol too increases the risk of premature birth.

Study shows that de novo mutations can be detected in human in vitro fertilized embryos using PGD

Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro fertilization (IVF).

New discovery opens new therapeutic opportunities for treatment of cancer and tissue fibrosis

Researchers from the Turku Centre for Biotechnology (BTK) in Finland have discovered that a cellular fuel sensor, known to control energy processes in the cells, is involved in the regulation of the contact of cells with their surrounding environment.

Read more Medical News

› Verified 9 days ago

Entity NameMainehealth
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790265502
PECOS PAC ID: 7517860588
Enrollment ID: O20040701000166

News Archive

People with SIRT1 genetic variation more likely to develop vibration-induced white finger disease

Vibration-induced white finger disease (VWF) is caused by continued use of vibrating hand held machinery (high frequency vibration >50 Hz), and affects tens of thousands of people. New research published in BioMed Central's open access journal Clinical Epigenetics finds that people with a genetic polymorphism (A2191G) in sirtuin1 (SIRT1), a protein involved in the regulation of endothelial NOS (eNOS), are more likely to suffer from vibration-induced white finger disease.

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

Cholesterol levels both high and low linked to premature births

A new study suggests that not only is a very low level of cholesterol a danger to pregnant women, but high cholesterol too increases the risk of premature birth.

Study shows that de novo mutations can be detected in human in vitro fertilized embryos using PGD

Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro fertilization (IVF).

New discovery opens new therapeutic opportunities for treatment of cancer and tissue fibrosis

Researchers from the Turku Centre for Biotechnology (BTK) in Finland have discovered that a cellular fuel sensor, known to control energy processes in the cells, is involved in the regulation of the contact of cells with their surrounding environment.

Read more Medical News

› Verified 9 days ago

Entity NameRumford Community Family Health Center Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578599775
PECOS PAC ID: 1557340460
Enrollment ID: O20040715000176

News Archive

People with SIRT1 genetic variation more likely to develop vibration-induced white finger disease

Vibration-induced white finger disease (VWF) is caused by continued use of vibrating hand held machinery (high frequency vibration >50 Hz), and affects tens of thousands of people. New research published in BioMed Central's open access journal Clinical Epigenetics finds that people with a genetic polymorphism (A2191G) in sirtuin1 (SIRT1), a protein involved in the regulation of endothelial NOS (eNOS), are more likely to suffer from vibration-induced white finger disease.

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

Cholesterol levels both high and low linked to premature births

A new study suggests that not only is a very low level of cholesterol a danger to pregnant women, but high cholesterol too increases the risk of premature birth.

Study shows that de novo mutations can be detected in human in vitro fertilized embryos using PGD

Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro fertilization (IVF).

New discovery opens new therapeutic opportunities for treatment of cancer and tissue fibrosis

Researchers from the Turku Centre for Biotechnology (BTK) in Finland have discovered that a cellular fuel sensor, known to control energy processes in the cells, is involved in the regulation of the contact of cells with their surrounding environment.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kristin K Jhamb is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kristin K Jhamb, MD
1 Wellness Way, Suite A,
Topsham, ME 04086-1768

Ph: (207) 406-7600
Kristin K Jhamb, MD
1 Wellness Way, Suite A,
Topsham, ME 04086-1768

Ph: (207) 406-7600

News Archive

People with SIRT1 genetic variation more likely to develop vibration-induced white finger disease

Vibration-induced white finger disease (VWF) is caused by continued use of vibrating hand held machinery (high frequency vibration >50 Hz), and affects tens of thousands of people. New research published in BioMed Central's open access journal Clinical Epigenetics finds that people with a genetic polymorphism (A2191G) in sirtuin1 (SIRT1), a protein involved in the regulation of endothelial NOS (eNOS), are more likely to suffer from vibration-induced white finger disease.

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

Cholesterol levels both high and low linked to premature births

A new study suggests that not only is a very low level of cholesterol a danger to pregnant women, but high cholesterol too increases the risk of premature birth.

Study shows that de novo mutations can be detected in human in vitro fertilized embryos using PGD

Reprogenetics, the largest U.S. genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD), announced today the publication of new clinical data in the March issue of Genome Research demonstrating that de novo single base mutations can be detected in embryos after in vitro fertilization (IVF).

New discovery opens new therapeutic opportunities for treatment of cancer and tissue fibrosis

Researchers from the Turku Centre for Biotechnology (BTK) in Finland have discovered that a cellular fuel sensor, known to control energy processes in the cells, is involved in the regulation of the contact of cells with their surrounding environment.

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Topsham, ME

Dr. Bryan Christopher Lewis, M.D.
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1 Wellness Way Ste A, Topsham, ME 04086
Phone: 207-406-7600    Fax: 207-406-7601
Dr. Brian Roger Haney, DO
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 105 Topsham Fair Mall Rd Unit 1, Topsham, ME 04086
Phone: 207-303-3300    Fax: 207-250-2137
Dr. David Conner Benton, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 105 Topsham Fair Mall Rd Unit 1, Topsham, ME 04086
Phone: 207-303-3300    Fax: 207-250-2137
Jennifer M Riehl, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 1 Wellness Way, Suite A, Topsham, ME 04086
Phone: 207-406-7600    Fax: 207-406-7601
Dr. Julia Moukharskaya, MD
Internal Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 105 Topsham Fair Mall Rd Unit 1, Topsham, ME 04086
Phone: 207-303-3300    Fax: 207-250-2137
Dr. John Joseph Parker, MD
Internal Medicine
Medicare: Medicare Enrolled
Practice Location: 1 Wellness Way, Suite A, Topsham, ME 04086
Phone: 207-406-7600    Fax: 207-406-7601

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.